Coeptis Therapeutics Warrants
COEPW
COEPW was delisted on the 24th of April, 2026.
17 hedge funds and large institutions have $1.81M invested in Coeptis Therapeutics Warrants in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
89% more funds holding
Funds holding: 9 → 17 (+8)
12% less capital invested
Capital invested by funds: $2.05M → $1.81M (-$242K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$563K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$143K |
| 3 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$141K |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$123K |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$122K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$255K |
| 2 |
OCAM
Owl Creek Asset Management
New York
|
-$188K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$8K |
COEPW Hedge Fund Activity: Q1 2021 in Review
17 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q1 2021, worth a combined $1.81M — down 12% from $2.05M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new COEPW positions and 1 closed out — a net gain of 8 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $563K. The largest seller was Shaolin Capital Management, cutting an estimated $255K.
- 17 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q1 2021, up from 9 in Q4 2020.
- Funds reported $1.81M of Coeptis Therapeutics Warrants stock for Q1 2021, down 12% quarter-over-quarter.
- 9 funds opened new Coeptis Therapeutics Warrants positions in Q1 2021 and 1 closed out, a net change of +8 holders.
- The largest Coeptis Therapeutics Warrants buyer in Q1 2021 was Citadel Advisors, an estimated $563K added.
- The largest Coeptis Therapeutics Warrants seller in Q1 2021 was Shaolin Capital Management, an estimated $255K sold.
Based on aggregated 13F filings for Q1 2021.